Literature DB >> 24671701

Acute generalized exanthematous pustulosis induced by sorafenib.

Maider Pretel1, Mercedes Iñarrairaegui1, José Miguel Lera1, Leyre Aguado1, Miguel Angel Idoate2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24671701     DOI： 10.1001/jamadermatol.2013.6924

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

Review 1.  Management of the cutaneous adverse effects of antimelanoma therapy.

Authors:  Rose Congwei Liu; Germana Consuegra; Pablo Fernández-Peñas
Journal:  Melanoma Manag       Date:  2017-11-22

2.  Pancreatitis-associated with riluzole; linezolid-induced hypoglycemia; sorafenib-induced acute generalized exanthematous pustulosis; creatine supplementation-induced thrombotic events; acute pancreatitis associated with quetiapine; hypomagnesemia and seizure associated with rabeprazole.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2014-12

3.  Pustular drug eruption due to Panax notoginseng saponins.

Authors:  ZhiQiang Yin; LiWen Ma; JiaLi Xu; JiPing Xia; Dan Luo
Journal:  Drug Des Devel Ther       Date:  2014-07-16       Impact factor: 4.162

Review 4.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

Review 5.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.